Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLOC-ICH phase II trial of anakinra in intracerebral haemorrhage
2018-000249-38Phase 2Unknown
- Sponsor
- The University of Manchester
- Start
- Jun 2019
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of anakinra in intracerebral hemorrhage (ICH), sponsored by The University of Manchester. Primary endpoint: Perihaematomal oedema at 72 hours. Status: unknown.
02
Drugs
anakinra
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on 2018-000249-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000249-38.